BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.59
-0.24 (-3.07%)
At close: Dec 5, 2025, 4:00 PM EST
7.62
+0.03 (0.40%)
After-hours: Dec 5, 2025, 7:10 PM EST
BioCryst Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,598 | 1,558 | 1,227 | 2,140 | 2,492 | 1,315 | |
| Market Cap Growth | 9.27% | 26.97% | -42.68% | -14.12% | 89.45% | 147.49% | |
| Enterprise Value | 2,068 | 2,070 | 1,675 | 2,435 | 2,603 | 1,253 | |
| Last Close Price | 7.59 | 7.52 | 5.99 | 11.48 | 13.85 | 7.45 | |
| PS Ratio | 2.64 | 3.46 | 3.70 | 7.90 | 15.86 | 73.85 | |
| PB Ratio | - | -3.27 | -2.69 | -7.26 | -23.29 | -68.29 | |
| EV/Sales Ratio | 3.45 | 4.59 | 5.05 | 8.99 | 16.56 | 70.34 | |
| EV/EBITDA Ratio | 25.72 | 1194.32 | - | - | - | - | |
| Debt / Equity Ratio | -1.76 | -1.77 | -1.86 | -2.52 | -5.54 | -14.51 | |
| Debt / EBITDA Ratio | 8.27 | 208.58 | - | - | - | - | |
| Asset Turnover | 1.28 | 0.90 | 0.62 | 0.48 | 0.34 | 0.07 | |
| Inventory Turnover | 29.60 | 10.11 | 7.71 | 12.00 | 18.93 | - | |
| Quick Ratio | 1.60 | 2.49 | 2.97 | 4.50 | 5.18 | 2.93 | |
| Current Ratio | 1.87 | 2.63 | 3.31 | 4.89 | 5.46 | 3.07 | |
| Return on Equity (ROE) | - | - | - | - | - | -1925.37% | |
| Return on Assets (ROA) | 10.31% | -0.16% | -11.57% | -16.30% | -24.07% | -41.60% | |
| Return on Capital (ROIC) | 14.46% | -0.21% | -14.70% | -19.88% | -29.76% | -55.37% | |
| Return on Capital Employed (ROCE) | 30.20% | -0.40% | -26.90% | -33.40% | -36.70% | -74.10% | |
| Earnings Yield | -0.55% | -5.71% | -18.47% | -11.55% | -7.39% | -13.90% | |
| FCF Yield | 2.99% | -3.41% | -7.93% | -7.63% | -5.80% | -10.31% | |
| Buyback Yield / Dilution | -1.84% | -7.54% | -3.38% | -3.79% | -7.08% | -44.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.